| Patent Number |
Title Of Patent |
Date Issued |
| 7635768 |
Methods and reagents for dendritic localization of polynucleotides |
December 22, 2009 |
| A recombinant nucleic acid comprising nucleotides corresponding to a 3.2 kb 3' untranslated region present in mouse calcium calmodulin kinase II alpha subunit-encoding mRNA is provided. An isolated nucleic acid which hybridizes to the 3' untranslated region of mouse calcium calmodulin |
| 7015190 |
Method for enhancing long-term memory in a subject and uses thereof |
March 21, 2006 |
| The present invention provides for a method to enhance long-term memory in a subject whose cAMP-responsive gene expression is repressed due to binding of a cAMP-response-element-binding-protein-2 to a protein or a DNA associated with cAMP-responsive gene expression, or both, which co |
| 6703485 |
Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
March 9, 2004 |
| The present invention provides an isolated nucleic acid encoding a BCNG protein or a portion thereof or BCNG-related protein or a portion thereof. The present invention further provides a method for identifying a nucleic acid in a sample which encodes a BCNG protein or a BCNG-related pro |
| 6551821 |
Brain cyclic nucleotide gated ion channel and uses thereof |
April 22, 2003 |
| The present invention provides an isolated nucleic acid molecule encoding a brain cyclic nucleotide gated ion channel (BCNG) protein. An isolated BCNG protein is also provided as is a composition comprising a BCNG encoding nucleic acid or protein or a portion thereof. The present inventi |
| 6509190 |
DNA regulatory element for the expression of transgenes in neurons of the mouse forebrain |
January 21, 2003 |
| The present invention provides for a recombinant DNA construct for expressing a gene of interest comprising a mouse calcium-calmodulin-dependent kinase IIa promoter operatively linked to a gene of interest. The present invention also provides for a murine neuronal cell line which has |
| 6096302 |
Assay for the measurement of neuronal degradation and uses thereof |
August 1, 2000 |
| The present invention provides a method to determine the extent of neuronal degradation due to aging, a learning disability, or a neurological disorder, which includes: (a) stimulating a neuronal cell population under suitable conditions so as to induce a late-phase long term potentiatio |
